Access the Full Agenda With 3 Days of Unrivalled Content &
20+ Industry-Leading Speakers

Screenshot (179)

Having trouble downloading the brochure? Let us know and we’ll email it to you instead

Uncover insights to get the first step of your ADC development right:

  • Survey the current novel target landscape to aid in the next step of your target selection and pipeline strategy with Seagen and Bicycle Therapeutics
  • Apply learnings from clinically validated targets to develop first- or best-in-class ADCs with AbbVie and AstraZeneca
  • Re-examine what makes a good ADC target with target biology with Dynamicure and Cancer Research Horizons
  • Utilize proteomics and bioinformatics to identify and validate the best targets for your technology with Innovent Biologics and Zymeworks
  • Tackle your complex strategic decisions on pipeline development and lead candidate selection with Hillstream Biopharma and Bolt Biotherapeutics

Excellent conference, definitely worth attending for anyone looking to learn more about targets in the context of ADCs

Triphase Accelerator